Literature DB >> 10780964

An improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscle.

N H Prins1, N P Shankley, N J Welsh, M R Briejer, R A Lefebvre, L M Akkermans, J A Schuurkes.   

Abstract

Recently, it was demonstrated that 5-HT induces relaxation of human colon circular muscle through activation of 5-HT(4) receptors and 5-HT(7) receptors. The aim of the current study was to develop a new in vitro bioassay of human colon that would facilitate the pharmacological analysis of 5-HT responses mediated solely by 5-HT(4) receptors. Contracting circular muscle strips with KCl (80 mM) yielded a stable contractile tension and, in contrast to muscarinic cholinoceptor agonists and histamine, a profound reduction of spontaneous contractility. This allowed the establishment of reproducible, fully-defined, agonist concentration-response curves by cumulative dosing. Under these conditions, 5-HT induced a concentration-dependent relaxation (pEC(50) 7.31, Hill slope 0.91). Neither methysergide (10 microM) nor granisetron (1 microM) affected the 5-HT-induced relaxation, suggesting that 5-HT(1), 5-HT(2), 5-HT(3), 5-ht(5), 5-HT(6) or 5-HT(7) receptors are not involved. The lack of effect of tetrodotoxin (0.3 microM) indicated a direct effect of 5-HT on the smooth muscle. The selective 5-HT(4) receptor antagonists GR 113808, GR 125487 and RS 39604 competitively antagonized the 5-HT-induced relaxation (pK(B) 9.43, 10.12 and 8.53, respectively). SB 204070 (1 nM) produced a rightward shift (pA(2) 10.34) and depression of the 5-HT curve. These affinity estimates are similar to those previously reported for 5-HT(4) receptors. The selective 5-HT(4) receptor agonists, prucalopride and R076186, induced relaxations (pEC(50) 7.50 and 7.57, respectively), that were blocked by GR 113808 (3 nM), yielding pA(2) estimates of 9.31 and 9.21, respectively. To summarise, in KCl (80 mM)-contracted muscle strips, 5-HT induces relaxation through activation of a homogeneous smooth muscle 5-HT(4) receptor population. This new bioassay allows the focused, pharmacological characterization of human colonic 5-HT(4) receptors in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780964      PMCID: PMC1572010          DOI: 10.1038/sj.bjp.0703254

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Evidence for 5-HT7 receptors mediating relaxation of human colonic circular smooth muscle.

Authors:  N H Prins; M R Briejer; P J Van Bergen; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

2.  Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT.

Authors:  R A Borman; D E Burleigh
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

3.  A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.

Authors:  A Dumuis; R Bouhelal; M Sebben; R Cory; J Bockaert
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

4.  Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).

Authors:  G J Sanger; D R Nelson
Journal:  Eur J Pharmacol       Date:  1989-01-10       Impact factor: 4.432

5.  Blockade of human atrial 5-HT4 receptors by GR 113808.

Authors:  A J Kaumann
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay.

Authors:  J W Black; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

7.  Cisapride and a structural analogue, R 76,186, are 5-hydroxytryptamine4 (5-HT4) receptor agonists on the guinea-pig colon ascendens.

Authors:  M R Briejer; L M Akkermans; A L Meulemans; R A Lefebvre; J A Schuurkes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain.

Authors:  C J Grossman; G J Kilpatrick; K T Bunce
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

10.  GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.

Authors:  J D Gale; C J Grossman; J W Whitehead; A W Oxford; K T Bunce; P P Humphrey
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

View more
  16 in total

Review 1.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

2.  5-HT(4) receptors mediating enhancement of contractility in canine stomach; an in vitro and in vivo study.

Authors:  N H Prins; A van Der Grijn; R A Lefebvre; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

3.  Divergent changes to muscarinic and serotonergic signalling following colitis.

Authors:  R W Wells; M G Blennerhassett
Journal:  Gut       Date:  2005-07-13       Impact factor: 23.059

4.  Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors: comparison with recombinant human 5-HT4 splice variants.

Authors:  Kurt A Krobert; Trond Brattelid; Finn Olav Levy; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-13       Impact factor: 3.000

5.  5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle.

Authors:  N H Prins; L M Akkermans; R A Lefebvre; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Presynaptic modulation of cholinergic neurotransmission in the human proximal stomach.

Authors:  Pascal G Leclere; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 7.  Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias.

Authors:  J R Giudicessi; M J Ackerman; M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2018-02-14       Impact factor: 3.598

8.  Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i).

Authors:  Trond Brattelid; Ane M Kvingedal; Kurt A Krobert; Kjetil W Andressen; Trond Bach; Marit E Hystad; Alberto J Kaumann; Finn Olav Levy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-30       Impact factor: 3.000

Review 9.  Prucalopride: a review of its use in the management of chronic constipation.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

10.  Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.

Authors:  Nicholas L Meyers; Roger I Hickling
Journal:  Drugs R D       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.